Leadership Overview
The Ritedose has 4 executives leading key functions including strategy, information technology, finance, and human resources.
Driven by operational excellence, The Ritedose is dedicated to advancing pharmaceutical manufacturing through innovative packaging solutions and a commitment to quality, impacting healthcare delivery across the United States.
Driven by operational excellence, The Ritedose is dedicated to advancing pharmaceutical manufacturing through innovative packaging solutions and a commitment to quality, impacting healthcare delivery across the United States.
Leadership Roles at The Ritedose
Jody Chastain - President & Chief Executive Officer
Jody Chastain, the President & Chief Executive Officer at The Ritedose, directs the overarching corporate strategy and operational execution for the pharmaceutical manufacturing and packaging facility. Overseeing all business units, Chastain ensures alignment with the company's mission of delivering high-quality pharmaceutical products. This leadership role involves driving innovation in manufacturing processes and expanding market reach within the United States. By optimizing resource allocation and fostering a culture of continuous improvement, Jody Chastain directly impacts the company's growth and its ability to serve healthcare needs. Ultimately, Chastain secures the long-term viability and strategic direction of The Ritedose.
Duane Miskelly - Chief Financial Officer
Duane Miskelly, the Chief Financial Officer at The Ritedose, directs all financial planning, management, and reporting activities for the organization. Overseeing fiscal operations, Miskelly ensures the company's financial health and compliance with all regulatory requirements. This leadership role involves managing budgets, analyzing financial performance, and developing strategies to optimize profitability and resource allocation. By meticulously managing financial resources, Duane Miskelly directly supports the company's manufacturing and packaging operations and its overall business objectives. Ultimately, Miskelly provides critical financial insights to guide strategic decision-making and ensure sustainable growth for The Ritedose.
Shawn Miller - Chief Information Officer
Shawn Miller, the Chief Information Officer at The Ritedose, architects and manages the company's entire technology infrastructure, ensuring robust and secure information systems. Overseeing all digital operations, Miller drives the implementation of advanced IT solutions that support manufacturing efficiency and data integrity. This leadership role involves safeguarding sensitive company and client data, enhancing cybersecurity protocols, and leveraging technology to streamline internal processes. By optimizing the technological framework, Shawn Miller directly supports the company's operational goals and its commitment to reliable pharmaceutical packaging. Ultimately, Miller ensures that The Ritedose maintains a competitive edge through strategic technological advancements.
Janisha Mshrm - Chief Human Resource Officer
Janisha Mshrm, the Chief Human Resource Officer at The Ritedose, leads all human capital management initiatives, fostering a productive and compliant work environment. Overseeing talent acquisition, employee relations, and organizational development, Mshrm ensures the company attracts and retains skilled professionals essential for pharmaceutical manufacturing. This leadership role involves developing and implementing HR policies that align with business objectives and support employee well-being. By cultivating a strong organizational culture and managing workforce dynamics, Janisha Mshrm directly contributes to the operational efficiency and success of The Ritedose. Ultimately, Mshrm champions the company's most valuable asset: its people.
Explore Leadership Teams in Manufacturing
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities.
Company Leadership NL
SS
MP
SC
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
MA
NC
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
RP
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
RG
RL
Frequently Asked Questions Regarding The Ritedose Top Executives and Leadership Team
